Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

A range of different techniques are available for predictive biomarker testing for non-small-cell lung cancer (NSCLC) clinical management. International guidelines suggest next-generation sequencing (NGS) as the preferred procedure, but other reverse transcriptase-polymerase chain reaction (RT-PCR)-...

Full description

Bibliographic Details
Main Authors: Alvaro Leone, Lucia Anna Muscarella, Paolo Graziano, Andrea Tornese, Lucia Rosalba Grillo, Angela Di Lorenzo, Monica Bronzini, Stefania Scarpino, Angelo Sparaneo, Giulio Rossi
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
non-small-cell lung cancer
ALK
ROS1
RET
MET
NTRK
Online Access:https://www.mdpi.com/2072-6694/15/1/292

Internet

https://www.mdpi.com/2072-6694/15/1/292

Similar Items